Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Current Practice Study of Rituxan in Patient Receiving BEAM Chemotherapy and Autologous Blood Stem Cell Transplantation for High Risk Lymphoma or Hodgkin's Disease

NCT01702961 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01702961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01702961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Current Practice Study of Rituxan in Patient Receiving BEAM Chemotherapy and Autologous Blood Stem Cell Transplantation for High Risk Lymphoma or Hodgkin's Disease
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2002
Completion date
January 31, 2017
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease, lymphoma